Клиника восстановления волос под руководством хирурга в Леванте, Стамбул, с 2007 года.
Смотреть всё →Пришлите 3–5 фотографий. Личный ответ в течение 24 часов — без посредников.
Запросить сейчас →FUE, DHI or Algorithmic FUE™ — Dr. Arslan recommends based on your photographs and Norwood stage.
Получить оценку → Открыть калькулятор →Член FUE Europe. Клиника аккредитована Министерством здравоохранения. Левент, Стамбул — на 60–80% дешевле, чем в Великобритании или США.
Смотреть пакет →Член FUE Europe. Аккредитован Министерством здравоохранения. 17+ лет. 4500+ операций, выполненных лично. Один пациент в день.
Полный профиль →Каждый графт установлен лично. За каждый результат — личная ответственность.
Читать о подходе →Без скрытых расходов. Отель, трансферы, операция и уход в одной цене.
Смотреть цены →Silver · Gold · VIP — отель 5★ · трансферы из аэропорта · PRP включено
Смотреть цены → Калькулятор графтов →Каждый случай выполнен лично доктором Арсланом Мусбехом.
Вся галерея →Не каждый случай требует пересадки. Медикаментозное лечение, терапии и специализированные решения.
Обзор →Руководства, инструменты и экспертные материалы — от доктора Арслана Мусбеха.
Все статьи →The short answer: a lifetime. Transplanted hair follicles are taken from donor zones that are genetically resistant to DHT — the hormone responsible for pattern hair loss. This resistance is encoded in the follicle itself, not in its location. It moves with the follicle to the recipient zone and persists throughout the patient's life. The transplanted hair is permanent. But there is important nuance to understand about what changes over time — and what does not.
Hair transplant permanence is based on a biological principle called donor dominance, first described by Dr. Norman Orentreich in 1959. His observation: transplanted hair follicles retain the characteristics of their donor location, not their recipient location. A follicle from the DHT-resistant occipital donor zone transplanted to the DHT-sensitive frontal scalp continues to behave as a DHT-resistant follicle.
Sixty-five years of clinical evidence across tens of millions of procedures confirms this principle. When correctly executed hair transplant produces a natural result at 12 months, that result is permanent. The transplanted hair will continue to grow for the patient's lifetime.
If you are evaluating whether a hair transplant procedure is worth the investment, the permanence question is foundational to the decision.

| Timeframe | Transplanted hair | Native surrounding hair |
|---|---|---|
| Year 1 | Full maturation — permanent result | Continues loss without Finasteride |
| Years 2–5 | Stable, growing normally | Gradual recession continues |
| Years 5–10 | May begin to grey naturally | Significant thinning possible |
| Years 10–15 | Still present, same follicles | May create contrast with transplanted zone |
| Year 20+ | Permanent — grows throughout life | Advanced loss possible without management |
Transplanted hair is not frozen in time. It ages like all hair — it may grey, it may thin very slightly with advancing age due to normal biological ageing of the follicle (not DHT-related miniaturisation). These changes are normal and expected. They are the ageing of a permanent asset, not the loss of it.
Greying: Transplanted hair follows the same greying timeline as the donor zone hair. If a patient's occipital donor hair is greying, transplanted hair will eventually grey to the same degree. This is typically welcome — a natural-looking grey hairline rather than the incongruity of dark transplanted hair against greying surrounding hair.
Calibre change: Very long-term (20+ years), transplanted hair may thin very slightly in calibre due to normal follicle senescence. This is subtle and gradual — not comparable to the dramatic miniaturisation of DHT-affected follicles.
The most important long-term consideration after hair transplant is not the transplanted hair — it is the native hair surrounding it. Androgenetic alopecia continues after surgery unless treated medically. Native follicles in the frontal scalp, mid-scalp and crown continue to be exposed to DHT. Without medical management, this produces a progressive mismatch between the permanent transplanted result and the continuing recession of surrounding native hair.
This is why Dr. Arslan's approach includes long-term medical management planning for every patient: Finasteride (where appropriate) to slow or stop native hair loss progression, Minoxidil to extend anagen and thicken miniaturised native hairs, and scheduled reassessments to monitor native hair status at 3–5 year intervals. The transplanted result is permanent; the management of native hair is ongoing.
Dr. Arslan's detailed approach to long-term planning is explained at Hairmedico About Us.

View long-term care planning options at hairmedico.com/price.
A hair transplant lasts a lifetime. Transplanted follicles are DHT-resistant and do not undergo the miniaturisation that causes pattern baldness. 65 years of clinical evidence confirms this. The transplanted hair will grey and age normally but will not fall out due to genetic hair loss.
After 20 years, transplanted hair continues to grow. It will grey naturally, matching the donor zone's greying timeline. Very gradual calibre thinning may occur due to normal biological ageing — not the miniaturisation of androgenetic alopecia. The result from month 12 remains stable for life.
Possibly — not because transplanted hair fails, but because surrounding native hair may continue to recede. Patients who use Finasteride maintain native hair better and less often need supplementary sessions. Long-term planning at the initial consultation accounts for anticipated future loss.
Permanently. Transplanted follicles are DHT-resistant and grow for life. 65+ years of clinical evidence confirms this.
Still growing — same follicles, same result. The hair may grey naturally but will not undergo pattern baldness miniaturisation.
Possibly — not because transplanted hair fails, but because surrounding native hair may continue to recede. Finasteride significantly reduces this risk.
All references are peer-reviewed medical publications. No commercial sources.